Member Info for NorthernHero

'Lots' = seven. :-)

If anyone wants to 'load up' they'd be better off waiting for the next placing; Because you will be able to get them at a fraction of the most recent 10p, 11p, 6p and 0.65p placings.

The lab is still not profitable and there's no revenue coming from anywhere else.

Why anyone would want to 'load up' with stock from a company in a state of continual decline (see placing prices above) is beyond me.

On a mission to pump the SP as high as possible before the impending placing.

Not working though is it?

Getting any income from those warrants are pure fantasy now. Especially, as they can't get CLX sold in time. They keep expanding the programme and subsequently, the timeline. CLX was the only thing that was going to save this company but the perpetual tinkering is set to result in another dilution.

I see PM2022 has a new account name on here ;-)

Same old VAL though innit.

The countdown to the next placing has started.

Expect more of these baseless RNS's over the next few weeks.

CLX has to go. End of.

It may not be as developed as they would like it to be, but they don't have the luxury of time.

If they are targeting warrant cash to avoid another placing, that speaks volumes.

Is this the same lab they were anticipating to turn profitable in H1? ;-)

So they extended the option to complete the licence agreement over six months ago because they hadn't completed their fundraising.

Now the licence agreement completes, there is no upfront payment and the first £6m in royalties can be paid in cash they currently don't have or Ambrose stock???

I can't see the benefit of VAL holding any Ambrose stock. They need INCOME!

Thanks. For. That.

This webinar is probably the first action in the lead up to another placing.

Just priming SH's, giving them false hope.

The warrants are only going to be worth executing when the SP is well north of 1.3p, which is looking less likely each day.

Some may also choose not to execute them for whatever reason. Using the total figure possible that could be recouped from these in any future income is fanciful at best, most likely desperate.

What happened to the lab being profitable in H1.

That's straight from the Suzy D school of fibs.

Will you be buying more stock in the next placing?

We'll get a heads up when it's coming, because the bull$hit RNS's (collaboration agreements etc.) will increase in volume. Everybody is well versed in the script now.

'Watch now to understand how ValiRx is navigating today’s landscape, and preparing for what comes next.'..............

Almost certainly, another placing.

May came and went didn't it!

Oh no, it isn't! 😉

Anyone who STILL thinks a star trek quote is humorous after all this time, is clearly not worth your (or anyone else's) time, jinky.

Leave them to their cosplay circle jerkery, where their 'humour' belongs. 😉

The current MCap probably reflects how poorly the company is performing and how little confidence there is to turn it around.

VAL only do bad news. Just look at the RNS releases over the past few years. ME has compounded Suzy's efforts on this front.

Ambrose/401 should be the next failure they have lined up.

CLX001 is in the wrong hands.

VAL are just a lab services company and an unprofitable one at that.

What a huge mistake it was for the new CEO to can it when he had the chance.

Absolute amateur stuff.

This company will never learn. Failure is ingrained in their culture.

Who's to say Mark Treharnes's actual job title isn't Business Diminishing Manager...........in which case he's doing a fantastic job.